|Bid||0.00 x 1300|
|Ask||0.00 x 800|
|Day's range||32.84 - 34.83|
|52-week range||22.05 - 45.79|
|Beta (5Y monthly)||2.86|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Key Insights Surgery Partners' estimated fair value is US$25.76 based on 2 Stage Free Cash Flow to Equity With US$25.62...
Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2023 Earnings Call Transcript November 7, 2023 Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.19, expectations were $0.14. Operator: Good morning, ladies and gentlemen, and welcome to Surgery Partners’ Third Quarter of 2023 Earnings Call. Currently, all participants are in listen-only mode. A question-and-answer session will follow the […]
The headline numbers for Surgery Partners (SGRY) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.